Pharmacy design architect Bernstein & Associates, Architects (http://bernarch.com/Healthcare-Design-Pharmacy/) has been selected to provide pharmacy design consulting services for a new hospital pharmacy. Pharmacy design consulting services include: pharmacy programming, pharmacy planning, pharmacy design, and pharmacy equipment planning.
The pharmacy design project is for a complete new hospital pharmacy. The project includes all new: pharmacy receiving, pharmacy dispensing and compounding suite. Compounding suite includes: USP 797 compliant anteroom, USP 797 compliant hazardous compounding room, and USP 797 compliant non-hazardous compounding room, pharmacy receiving, pharmacy purchasing, and pharmacy department offices.
About Bernstein & Associates, Architects (www.bernarch.com):
Bernstein & Associates, Architects has specialized in healthcare and lab design and construction since the firm's founding in 1990. This architecture firm is well-known for pharmacy planning, pharmacy design and pharmacy construction, and has designed over (25) hospital pharmacies in the last 5 years, which have included USP 797 compliant pharmacy design and construction. The firm's principal --- William N. Bernstein, AIA --- is a well-known architect of pharmacies. He has written extensively on pharmacy design and construction including USP 797 compliant pharmacies.
Pharmacy design projects by Bernstein & Associates, Architects are featured on https://twitter.com/pharmacydesign
Mr. Bernstein's USP 797 articles can be found on the USP 797 website www.usp797.org - and the USP 797 blog http://www.usp797org.blogspot.com/ - and the USP 797 Twitter account www.twitter.com/usp797
Mr. Bernstein’s pharmacy design articles can be found on the pharmacy design website www.pharmacydesign.org – and the pharmacy design Twitter account https://twitter.com/pharmacydesign
For more information about healthcare and hospital design and construction, including pharmacy design and pharmacy construction, contact Bernstein & Associates, Architects at:
New York (Headquarters)
Bernstein & Associates, Architects
1201 Broadway - #803
New York, NY 10001
T: 212-463-8200
F: 888-214-0670
Email: info@bernarch.com
Also in Hartford, Princeton and Los Angeles
Saturday, February 9, 2013
Techniglove International Presents STN200P Series
Techniglove International
Sterile, Pair Packed, Powder Free, Class 100 Cleanroom Glove, Nitrile 12”, White
Techniglove’s new Latex Free STN200P Series meets requirements for USP 797 and Chemotherapy Drug Applications (see below for a complete list of approved drugs).
The sterile (gamma irradiated) STN200P is L/R pair-packed, one pair per wallet. This ambidextrous glove is offered in 6 sizes and provides the comfort, fit and feel of nitrile with a significant cost savings over hand specific versions.
Lot numbers and expiration dates are displayed on all levels of packaging and Certificate of Irradiaiton is provided both with product shipment and online at www.techniglove.com/COI
Techniglove Cleanroom Nitrile Gloves are double-Chlorinated, 100% nitrile, contain no natural rubber or silicone and meet the most stringent requirements for extractables and particles. They contain less than the allowable 20 EU/Device and are suitable for use in Pharmaceutical and Biotech manufacturing. All Techniglove products are manufactured in a Registered ISO9002 Facility.
Available in size XS-XXL (STN200P-STN205P).
1 Pair per Wallet, 20 Wallets per Master Bag, 200 Pairs per Case
******************
Additional USP 797 news can be found on the USP 797 website www.usp797.org - and the USP 797 blog http://www.usp797org.blogspot.com/ - and the USP 797 Twitter account www.twitter.com/usp797
Additional pharmacy design news can be found on the pharmacy design websitewww.pharmacydesign.org – and the pharmacy design Twitter account https://twitter.com/pharmacydesign
Aerobiology Laboratory Associates Celebrates 15 Years in Business
Aerobiology Laboratory Associates, headquartered in Dulles, Virginia, is a privately held, woman owned AIHA EMLAP accredited environmental microbiology laboratory.
Laboratories are located in the Washington DC area, Atlanta and Denver.
Celebrating 15 years in 2012, our clients are supported by a dedicated staff of advanced degreed bacteriologists and mycologists. Our services include bacterial and fungal identification, 797 compliance plan implementation and Infection Control and Risk Assessment (ICRA).
Suzanna Blevins, the owner and laboratory director can be reached at:
Suzane@aerobiology.net, www.aerobiology.net and 877-648-9150.
*****************
Additional USP 797 news can be found on the USP 797 website www.usp797.org - and the USP 797 blog http://www.usp797org.blogspot.com/ - and the USP 797 Twitter account www.twitter.com/usp797
Additional pharmacy design news can be found on the pharmacy design websitewww.pharmacydesign.org – and the pharmacy design Twitter account https://twitter.com/pharmacydesign
Acute Care Pharmaceutical Disposable Medical Products
For over 15 years, Acute Care Pharmaceuticals has been servicing the healthcare industry by delivering exceptional products and services to healthcare providers nationwide. Our disposable medical products are manufactured under the highest standards, resulting in reliable and compliant USP <797> disposable products.
We can supply your facility with the correct disposable products and the knowledge necessary to support the operation of your cleanroom facility and/or barrier isolator set up.
Our Pharma™-Brand products are available through Cardinal, McKesson, Amerisource Bergen, and online at new website, www.Pharma-Choice.com.
Contact: Director of Marketing
12225 World Trade Drive Suite A
San Diego, California 92128
E: Info@acutecareonline.com
P: 1.888.909.7700
***********************
Additional USP 797 news can be found on the USP 797 website www.usp797.org - and the USP 797 blog http://www.usp797org.blogspot.com/ - and the USP 797 Twitter account www.twitter.com/usp797
Additional pharmacy design news can be found on the pharmacy design websitewww.pharmacydesign.org – and the pharmacy design Twitter account https://twitter.com/pharmacydesign
Pharmacy Design Project Out To Bid for New Hospital Pharmacy in New York State
Pharmacy design architect Bernstein & Associates, Architects (http://bernarch.com/Healthcare-Design-Pharmacy/) is pleased to announce that a new hospital pharmacy, designed for a major teaching hospital, is now out to bid.
Pharmacy design services included: pharmacy planning, pharmacy design, pharmacy equipment planning, architectural and engineering services for the new pharmacy, pharmacy construction bidding, and pharmacy construction.
The pharmacy design project is for a complete new hospital pharmacy. The project includes all new: receiving, dispensing and compounding suite. Compounding suite includes: USP 797 compliant anteroom, new USP 797 compliant hazardous compounding room, and new USP 797 compliant non-hazardous compounding room.
About Bernstein & Associates, Architects (www.bernarch.com):
Bernstein & Associates, Architects has specialized in healthcare and lab design and construction since the firm's founding in 1990. This architecture firm is well-known for pharmacy planning, pharmacy design and pharmacy construction, including USP 797 compliant pharmacy design and construction. The firm's principal --- William N. Bernstein, AIA --- is a well-known architect of pharmacies. He has written extensively on pharmacy design and construction including USP 797 compliant pharmacies. Mr. Bernstein's USP 797 articles can be found on the USP 797 website www.usp797.org, and his pharmacy design articles can be found on the pharmacy design website www.pharmacydesign.org.
For more information about pharmacy design and pharmacy construction, contact Bernstein & Associates, Architects at:
New York (Headquarters)
Bernstein & Associates, Architects
1201 Broadway - #803, New York, NY 10001
T: 212-463-8200
F: 888-214-0670
www.bernarch.com
Also in Hartford, Princeton and Los Angeles
EMLab P&K’s Risk Assessment Pathogen Program
Dr. Joseph Manfrida from EMLab P&K’s Risk Assessment Pathogen Program begins collaboration with TestAmerica’s Ask the Expert webinar series
Dr. Joseph Manfrida has begun working with the TestAmerica Ask the Expert webinar series to bring additional opportunities for education to interested professionals. Originally known for his acclaimed presentations in bacteriology, nosocomial mycoses, and USP <797>, Dr. Manfrida is now presenting alongside the scientists of TestAmerica to create opportunities to discuss additional topics.
The Science and Ambiguity of Asbestos, will be presented on October 25th, 2012. The nature of asbestos, the threat it poses to human health, and the technologies available to investigate its presence are frequently misunderstood. Dr. Manfrida will be discussing the science behind asbestos contamination and how it interacts with the medical, legal, and technical aspects of detecting and removing the contaminate. Webinar attendees will leave with a greater understanding of the motivation and reasoning behind current practices regarding asbestos.
Course topics include:
• The controversy surrounding the definition of asbestos as well as give the current operative definition delineated by NIOSH
• Identifying the major types of asbestos
• Major medical conditions resulting from asbestos exposure and current hypotheses regarding how pathologies develop
• Current federal regulations applying to asbestos, including recommended exposure limits
• Technologies for asbestos testing
• Future goals of NIOSH asbestos research and regulation
Register at: http://www.testamericainc.com/services/webinar_series.aspx
Dr. Manfrida will discuss USP <797> on August 2nd, 2012. This USP <797> training course provides information regarding the background and purpose of USP <797> and will discuss designing and executing a USP <797> sampling regimen.
USP <797> course topics include:
• History and background of USP <797>
• Where USP <797> regulation applies
• Determining what types of testing are needed
• Designing a testing regimen
• Interpreting data
• Investigation and remediation of contamination *****************Additional USP 797 news can be found on the USP 797 website www.usp797.org - and the USP 797 blog http://www.usp797org.blogspot.com/ - and the USP 797 Twitter account www.twitter.com/usp797
The Science and Ambiguity of Asbestos, will be presented on October 25th, 2012. The nature of asbestos, the threat it poses to human health, and the technologies available to investigate its presence are frequently misunderstood. Dr. Manfrida will be discussing the science behind asbestos contamination and how it interacts with the medical, legal, and technical aspects of detecting and removing the contaminate. Webinar attendees will leave with a greater understanding of the motivation and reasoning behind current practices regarding asbestos.
Course topics include:
• The controversy surrounding the definition of asbestos as well as give the current operative definition delineated by NIOSH
• Identifying the major types of asbestos
• Major medical conditions resulting from asbestos exposure and current hypotheses regarding how pathologies develop
• Current federal regulations applying to asbestos, including recommended exposure limits
• Technologies for asbestos testing
• Future goals of NIOSH asbestos research and regulation
Register at: http://www.testamericainc.com/services/webinar_series.aspx
Dr. Manfrida will discuss USP <797> on August 2nd, 2012. This USP <797> training course provides information regarding the background and purpose of USP <797> and will discuss designing and executing a USP <797> sampling regimen.
USP <797> course topics include:
• History and background of USP <797>
• Where USP <797> regulation applies
• Determining what types of testing are needed
• Designing a testing regimen
• Interpreting data
• Investigation and remediation of contamination *****************Additional USP 797 news can be found on the USP 797 website www.usp797.org - and the USP 797 blog http://www.usp797org.blogspot.com/ - and the USP 797 Twitter account www.twitter.com/usp797
Additional pharmacy design news can be found on the pharmacy design websitewww.pharmacydesign.org – and the pharmacy design Twitter account https://twitter.com/pharmacydesign
Decon Labs, Inc. - Contamination Control Made Simpler
Decon Labs is the market leading manufacturer/supplier of disinfectants and cleaners made specifically for cleanrooms and compounding areas. Our wide range of sterile alcohol, sterile disinfectants, antimicrobial hand care products, pre-sat wipes, and cleaners will help you achieve USP 797 compliance. Our national distribution network makes our products readily available in local proximity to your compounding facilities. Decon’s trained staff will help you choose the proper product for your application making contamination control simple and easy.
Call us or visit our website to find out how we can help you. Toll Free 1-800-332-6647., www.deconlabs.com
Contact:
Mike Dunne
Decon Labs, Inc.
P 610.755.0800
F 610.270.8905
Mike Dunne
Decon Labs, Inc.
P 610.755.0800
F 610.270.8905
***************************Additional USP 797 news can be found on the USP
797 website www.usp797.org -
and the USP 797 blog http://www.usp797org.blogspot.com/ - and
the USP 797 Twitter account www.twitter.com/usp797
Additional pharmacy design news can be found on the pharmacy design websitewww.pharmacydesign.org – and the pharmacy design Twitter account https://twitter.com/pharmacydesign
Contec, Inc. Introduces QuicKlean™ Mop System with MicroGenesis™ Wipe
QuicKlean™ System makes ordering more convenient and economical.
Since its inception, the USP<797> market has struggled to find mopping systems to address their unique demands. Pharmacies have had to use products that are inadequate or considered excessive for use in their environments. The challenge that has been brought to our attention is to find ISO Class 7 cleanroom compatible materials that are not cost prohibitive and incorporate easy to use components. Pharmacies also need a system flexible enough to address all the USP<797> needs which include daily floor maintenance coupled with monthly ceiling and wall maintenance.
Contec worked with pharmacy technicians, buyers and directors to develop a system that meets all the USP<797> requirements. The result is the QuicKlean Mopping System. The new QuicKlean Mop System allows customers to use one part number for a smaller order of mop foam heads and covers - two bags of 50 MicroGenesis wipes, six foam mop heads. This is ideal for smaller pharmacies, labs and other critical areas where storage and space can be an issue. QuicKlean offers excellent performance, flexibility, convenience and affordability.
The QuicKlean™ Mop System is used with the latest microfiber wipe from Contec – the MicroGenesis™ wipe. MicroGenesis is a laundered microfiber wipe that is cut to 10” x 18” (25 x 46cm) so it can fit easily with the QuicKlean Mop System. Safe for use with most disinfectants, this system delivers the maximum amount of microfiber to pick-up and retain particles, dust, and other contaminants in cleanrooms and other critical applications.
For more information, please call 864-503-8333 or go to www.contecinc.com.
Contec worked with pharmacy technicians, buyers and directors to develop a system that meets all the USP<797> requirements. The result is the QuicKlean Mopping System. The new QuicKlean Mop System allows customers to use one part number for a smaller order of mop foam heads and covers - two bags of 50 MicroGenesis wipes, six foam mop heads. This is ideal for smaller pharmacies, labs and other critical areas where storage and space can be an issue. QuicKlean offers excellent performance, flexibility, convenience and affordability.
The QuicKlean™ Mop System is used with the latest microfiber wipe from Contec – the MicroGenesis™ wipe. MicroGenesis is a laundered microfiber wipe that is cut to 10” x 18” (25 x 46cm) so it can fit easily with the QuicKlean Mop System. Safe for use with most disinfectants, this system delivers the maximum amount of microfiber to pick-up and retain particles, dust, and other contaminants in cleanrooms and other critical applications.
For more information, please call 864-503-8333 or go to www.contecinc.com.
**************
Additional USP 797 news can be found on the USP 797 website www.usp797.org - and the USP 797 blog http://www.usp797org.blogspot.com/ - and the USP 797 Twitter account www.twitter.com/usp797
Additional pharmacy design news can be found on the pharmacy design website www.pharmacydesign.org – and the pharmacy design Twitter account https://twitter.com/pharmacydesign
Additional pharmacy design news can be found on the pharmacy design website www.pharmacydesign.org – and the pharmacy design Twitter account https://twitter.com/pharmacydesign
Charlotte Safety & CleanroomSupplyConnection.com Expand USP797 Division
Charlotte Safety and CleanroomSupplyConnection.com have expanded their compounding pharmacy and cleanroom product offerings due to recent growth and need of their pharmacy clients. We are now an authorized dealer of SPS Medical sterilization products as well as Criti Clean cleanroom wipes and cleanroom clothing. Charlotte Safety is a master stocking distributor of all cleanroom supplies and products needed for the largest compounding pharmacies – both independent as well as hospital pharmacies. We offer special pricing on cleanroom mops,cleanroom disinfectants, cleanroom clothing, cleanroom presaturated wipes, tacky floor mats,cleanroom swabs and everything else you need to keep your cleanroom in top shape. We work with the country’s most well respected research and pharmaceutical facilities and offer expert advice on supplies, USP 797 protocol and streamlining your cleanroom supply inventory.
We also stock sterile cleanroom supplies including sterile cleanroom coveralls, sterile cleanroom sleeves, sterile face masks and sterile cleanroom paper.
Please visit us online at www.CleanroomSupplyConnection.com or call our toll free phone at 1-800-616-5319.
Contact:
Peter Lojac
Charlotte Safety & CleanroomSupplyConnection.com
P 516.596.8781
F 516.596.8619
E Sales@CleanroomSupplyConnection.com
***************
Additional USP 797 news can be found on the USP 797 website www.usp797.org - and the USP 797 blog http://www.usp797org.blogspot.com/ - and the USP 797 Twitter account www.twitter.com/usp797
Additional pharmacy design news can be found on the pharmacy design website www.pharmacydesign.org – and the pharmacy design Twitter account https://twitter.com/pharmacydesign
Subscribe to:
Posts (Atom)